Two Sigma Investments, LP G1 Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.2 - $4.98 $55,673 - $126,023	-25,306 Reduced 7.57%	308,825 $704,000
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $361,342 - $831,088	172,068 Added 106.17%	334,131 $1.44 Million
Q4 2023 Feb 14, 2024	BUY	$1.12 - $3.73 $80,262 - $267,302	71,663 Added 79.27%	162,063 $494,000
Q3 2023 Nov 14, 2023	BUY	$1.22 - $2.67 $110,288 - $241,368	90,400 New	90,400 $130,000
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $769,766 - $2.44 Million	-299,520 Reduced 74.27%	103,783 $278,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $732,417 - $1.91 Million	141,121 Added 53.83%	403,303 $2.19 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $776,792 - $2.55 Million	150,250 Added 134.23%	262,182 $3.28 Million
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $355,709 - $749,279	88,047 Added 368.63%	111,932 $553,000
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $853,860 - $1.24 Million	-112,350 Reduced 82.47%	23,885 $182,000
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $523,280 - $832,819	51,504 Added 60.79%	136,235 $1.39 Million
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $7.12 Million - $12.2 Million	-541,023 Reduced 86.46%	84,731 $1.14 Million
Q2 2021 Aug 16, 2021	SELL	$19.57 - $26.32 $4.14 Million - $5.57 Million	-211,522 Reduced 25.26%	625,754 $13.7 Million
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $9.75 Million - $18.1 Million	554,801 Added 196.41%	837,276 $20.1 Million
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $1.31 Million - $2.43 Million	119,165 Added 72.97%	282,475 $5.08 Million
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $1.89 Million - $3.88 Million	163,310 New	163,310 $1.89 Million
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $1.16 Million - $2.95 Million	-121,049 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $491,394 - $1.43 Million	54,178 Added 81.02%	121,049 $1.33 Million
Q4 2019 Feb 14, 2020	BUY	$20.54 - $31.0 $1.14 Million - $1.72 Million	55,491 Added 487.62%	66,871 $1.77 Million
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $259,236 - $461,800	11,380 New	11,380 $259,000
Q2 2019 Aug 14, 2019	SELL	$16.03 - $31.1 $2.07 Million - $4.02 Million	-129,420 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $771,307 - $1.15 Million	53,563 Added 70.61%	129,420 $2.15 Million
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $1.25 Million - $3.89 Million	75,857 New	75,857 $1.45 Million
Q2 2018 Aug 14, 2018	SELL	$35.06 - $51.17 $1.48 Million - $2.16 Million	-42,305 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $332,079 - $727,960	17,432 Added 70.08%	42,305 $1.57 Million
Q4 2017 Feb 14, 2018	BUY	$19.01 - $26.2 $472,835 - $651,672	24,873	24,873 $493,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account